Ankit Mahadevia Spero Therapeutics, Inc. (SPRO) insider trading activity

SPRO Quotes by TradingView

Ankit Mahadevia is of Spero Therapeutics, Inc.. Currently has a direct ownership of 759,085 shares of SPRO, which is worth approximately $781,857. The most recent transaction as insider was on Aug 27, 2024, when has been sold 5,912 shares (Common Stock) at a price of $1.35 per share, resulting in proceeds of $7,981. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 759K
0% 3M change
6.15% 12M change
Total Value Held $781,857

Ankit Mahadevia Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 27 2024
SELL
Open market or private sale
$7,981 $1.35 p/Share
5,912 Reduced 0.77%
759,085 Common Stock
May 29 2024
BUY
Grant, award, or other acquisition
-
20,000 Added 2.55%
764,997 Common Stock
Feb 02 2024
SELL
Open market or private sale
$87,399 $1.37 p/Share
63,795 Reduced 7.89%
744,997 Common Stock
Oct 05 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 2.41%
808,792 Common Stock
Aug 28 2023
SELL
Open market or private sale
$11,390 $1.26 p/Share
9,040 Reduced 1.13%
788,792 Common Stock
Feb 03 2023
SELL
Open market or private sale
$22,237 $1.81 p/Share
12,286 Reduced 1.52%
797,832 Common Stock
Feb 01 2023
BUY
Grant, award, or other acquisition
-
531,914 Added 39.63%
810,118 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
-
134,168 Added 32.54%
278,204 Common Stock
Dec 27 2021
SELL
Open market or private sale
$116,640 $14.58 p/Share
8,000 Reduced 5.26%
144,036 Common Stock
Dec 27 2021
BUY
Exercise of conversion of derivative security
$47,200 $5.9 p/Share
8,000 Added 5.0%
152,036 Common Stock
Aug 26 2021
BUY
Grant, award, or other acquisition
-
78,219 Added 35.19%
144,036 Common Stock
Nov 04 2020
SELL
Open market or private sale
$106,349 $14.43 p/Share
7,370 Reduced 10.07%
65,817 Common Stock
Nov 04 2020
BUY
Exercise of conversion of derivative security
$43,483 $5.9 p/Share
7,370 Added 9.15%
73,187 Common Stock
Nov 03 2020
SELL
Open market or private sale
$30,495 $14.27 p/Share
2,137 Reduced 3.14%
65,817 Common Stock
Nov 03 2020
BUY
Exercise of conversion of derivative security
$12,608 $5.9 p/Share
2,137 Added 3.05%
67,954 Common Stock
Oct 23 2020
SELL
Open market or private sale
$285 $14.25 p/Share
20 Reduced 0.03%
65,817 Common Stock
Oct 23 2020
BUY
Exercise of conversion of derivative security
$118 $5.9 p/Share
20 Added 0.03%
65,837 Common Stock
Oct 14 2020
SELL
Open market or private sale
$1,496 $14.25 p/Share
105 Reduced 0.16%
65,817 Common Stock
Oct 14 2020
BUY
Exercise of conversion of derivative security
$620 $5.9 p/Share
105 Added 0.16%
65,922 Common Stock
Oct 13 2020
SELL
Open market or private sale
$205,161 $14.28 p/Share
14,367 Reduced 17.92%
65,817 Common Stock
Oct 13 2020
BUY
Exercise of conversion of derivative security
$84,765 $5.9 p/Share
14,367 Added 15.19%
80,184 Common Stock
AM

Ankit Mahadevia

Cambridge, MA

Track Institutional and Insider Activities on SPRO

Follow Spero Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SPRO shares.

Notify only if

Insider Trading

Get notified when an Spero Therapeutics, Inc. insider buys or sells SPRO shares.

Notify only if

News

Receive news related to Spero Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SPRO